Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Change in Account Payables (2021 - 2025)

Rxo (RXO) has disclosed Change in Account Payables for 5 consecutive years, with $58.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 422.22% year-over-year to $58.0 million, compared with a TTM value of -$16.0 million through Dec 2025, up 75.38%, and an annual FY2025 reading of -$16.0 million, up 75.38% over the prior year.
  • Change in Account Payables was $58.0 million for Q4 2025 at Rxo, up from $19.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $216.0 million in Q1 2022 and bottomed at -$121.0 million in Q2 2022.
  • Average Change in Account Payables over 5 years is -$4.8 million, with a median of -$20.0 million recorded in 2024.
  • Peak annual rise in Change in Account Payables hit 422.22% in 2025, while the deepest fall reached 364.29% in 2025.
  • Year by year, Change in Account Payables stood at $99.0 million in 2021, then plummeted by 139.39% to -$39.0 million in 2022, then grew by 23.08% to -$30.0 million in 2023, then soared by 40.0% to -$18.0 million in 2024, then soared by 422.22% to $58.0 million in 2025.
  • Business Quant data shows Change in Account Payables for RXO at $58.0 million in Q4 2025, $19.0 million in Q3 2025, and -$37.0 million in Q2 2025.